National and Kapodistrian University of Athens
Molecular mechanisms that underlie the modulation or inhibition of the function of human aminopeptidases
Abstract
dc:descriptionEndoplasmic reticulum aminopeptidases 1 and 2 (ERAPs) and insulin-regulated aminopeptidase (IRAP) play essential roles in adaptive immunity by generating mature antigenic peptides for MHC class I presentation. Their activity shapes the peptide repertoire presented to T cells and is associated with autoimmunity, cancer, and infectious diseases, while their polymorphic variation influences disease susceptibility. As a result, these enzymes have emerged as promising therapeutic targets. However, their high homology, as well as their complex and poorly understood mechanisms of function pose challenges for selective targeting. In this context, detailed understanding of their mechanism of action, modulation and substrate specificity is necessary. Notably, their catalytic mechanism involves large conformational transitions that can be affected by both allotypic variation and small molecules’ binding. To explore these mechanisms and their therapeutic potential, I focused on three main objectives: First, I studied the allotypic variation of ERAP1, focusing on the autoimmune-related allotype 10 and its unique polymorphic positions. By performing an array of biochemical and biophysical analyses, this project revealed that allotype 10’s distinct properties stem from shifts in the conformational equilibrium likely affecting a rate limiting step in the catalytic cycle. Secondly, I investigated different mechanisms of inhibition of IRAP by small molecules targeting both the active and an allosteric site. Combining structural and computational insights with biochemical assays, I demonstrate that stabilizing specific conformations enables substrate-selective inhibition, a promising approach for targeting distinct enzymatic functions. Finally, aiming to contribute to the design of selective inhibitors for ERAP2, I studied a series of substrate analogues, based on the bestatin scaffold. This work, combining structural and biochemical analysis, yielded a potent ERAP2 inhibitor with promising selectivity and cellular activity. Overall, this research advanced our understanding of the molecular and atomic mechanisms of these enzymes and generated novel insight into modulation strategies for specific therapeutic applications.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgaki, Evgenia-Galateia
- Γεωργάκη, Ευγενία-Γαλατεία
Subjects
dc:subject × 20- Αντιγονοπαρουσίαση
- Αμινοπεπτιδάσες
- Πολυμορφισμοί
- Διαμορφωτικές αλλαγές
- Μηχανισμός δράσης και αναστολής
- Antigen presentation
- Aminopeptidases
- Allotypic variation
- Conformational transitions
- Mechanism of action and inhibition
- Χημεία
- Φυσικές Επιστήμες
- Χημεία, άλλοι τομείς
- Βιολογία
- Βιοχημεία και Μοριακή βιολογία
- Chemical Sciences
- Natural Sciences
- Chemistry, miscellaneous
- Biological Sciences
- Biochemistry and Molecular Biology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59450